The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

计划入组 100 人 · 首次发布于 2021 年 9 月 5 日

Protocol DIVAT-Uro

计划入组 1,616 人 · 首次发布于 2011 年 1 月 21 日

Pivot Breath Sensor Performance Study

计划入组 70 人 · 首次发布于 2019 年 3 月 11 日

P-003+NK-002 (Pivot Pharmaceuticals)

Pivot Health Technologies INc.

United States

Pillar Biosciences and Hamilton Partner to Automate NGS Testing with Advanced Liquid Handling Systems

Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Partnership to China Amid High Cancer Burden

Pillar Biosciences Secures $34.5M Funding Round Led by Illumina to Advance NGS Cancer Testing Platform